The Concept of CMR

Key Points

• Type 2 diabetes is a significant CVD risk factor. However, the independent contribution of hyperglycemia per se to CVD risk remains uncertain.
• The hyperglycemic state of diabetes is only one of the dysmetabolic components observed in patients, who are often abdominally obese.
• The cluster of atherogenic metabolic abnormalities now often referred to as the metabolic syndrome is known to increase the risk of type 2 diabetes and CVD.
• Intervention trials have shown that reducing body weight in overweight and obese subjects at high risk of developing diabetes could substantially reduce their risk of developing diabetes.
• Age is also an important factor to consider when evaluating the CVD risk of diabetic patients.